Effects of dietary conjugated linoleic acid on oxidation markers and antioxidant defenses in rats with colorectal cancer

authors:

avatar Nasrin Beheshti , avatar Hosseein Davoodi , avatar Zahra kamal , avatar Morteza Abdollahi , avatar Marjan Ajami , *

Koomesh: Vol.19, issue 1; 233-240
article type: issue_documents_importer
received: February 01, 2016
accepted: July 02, 2016

how to cite: Beheshti N, Davoodi H, kamal Z, Abdollahi M, Ajami M. Effects of dietary conjugated linoleic acid on oxidation markers and antioxidant defenses in rats with colorectal cancer. koomesh. 2024;19(1):e151341. 

Abstract

Introduction: Colorectal cancer (CRC) is one of the most common types of cancer affecting 1.23 million individuals per year in the world. Recently, it is suggested that inflammation and oxidative stress play an importmat role in colorectal carcinogenesis. The aim of this syudy was to examine the effects of dietary conjugated linoleic acid (CLA) on oxidation markers and antioxidant defenses level in a rat model of colorectal cancer. Materials and Methods: Sixteen male Wistar rats, weighing 250-300 g were divided into two groups: control and experimental. Both groups were injected subcutaneously, with 1,2- Dimethyl Hydrazine at a dose of 15 mg/kg of body weight, twice per week for 6 weeks. The control group and experimental groups were gavaged with water (2 ml/kg) and CLA (200 mg/kg), respectively, for the first 4 weeks of study. After 6 weeks, the rats were killed and their blood and colorectal tissues were collected.  The serum levels of superoxide dismutase (SOD), glutation peroxidase (GPx), paraxonase (PON) and myeloperoxidase (MPO) and also malondialdehyde (MAD) level in the colorectal tissue were measured. Results: Findings indicated that MAD and MPO levels significantly decreased in the experimental group in comparison than the control group (P

References

  • 1.

    Ferlay J, Shin HR, Bray F, Forman D, Mathers C et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010; 127: 2893-2917.

  • 2.

    Roya Dolatkhah, Mohammad Hossein Somi, Mortaza Jabbarpour Bonyadi, Iraj Asvadi Kermani, et al. Colorectal cancer in Iran: molecular epidemiology and screening strategies. J Cancer Epidemiol 2015; 2015: 643020.

  • 3.

    Spunt S, Furman W, La Quaglia M, Bondy M, Goldberg R. Cancerepidemiology in older adolescents and young adults 15 to 29 years ofage. In: SEER AYA monograph. Bethesda (MD): National Cancer Institute; 2008. p. 12333.

  • 4.

    Joanna Kocot1, AF, Magorzata Kieczykowska1, C, E, Wojciech Dabrowski2, G et al. Total Antioxidant Status Value and Superoxide Dismutase Activity in Human Colorectal Cancer Tissue Depending on the Stage of the Disease: A Pilot Study. Adv Clin Exp Med 2013, 22, 431437.

  • 5.

    Crumb DJ, Conjugated Linoleic Acid (CLA)-An Overview. 2011 Sep-Oct; 4 (3). 12-18. Zidi I, Mestiri S, Bartegi A, Amor NB. TNF-alpha and its inhibitors in cancer. Med Oncol 2010; 27: 185-198.

  • 6.

    Carter AB, Misyak SA, Hontecillas R, Bassaganya-Riera J. Dietary modulation of inflammation-induced colorectal cancer through PPARgamma. PPAR Res 2009; 2009; 498352.

  • 7.

    Park Y, Storkson JM, Albright KJ, Liu W, Pariza MW. Evidence that the trans-10, cis-12 isomer of conjugated linoleic acid induces body composition changes in mice. Lipids 1999; 34: 235-241.

  • 8.

    Nagao K, Inoue N, Wang YM, Yanagita T. Conjugated linoleic acid enhances plasma adiponectin level and alleviates hyperinsulinemia and hypertension in Zucker diabetic fatty (fa/fa) rats. Biochem Biophys Res Commun 2003; 310: 562-566.

  • 9.

    Dai Y, Qiao L, Chan KW, Yang M, Ye J, Ma J, et al. Peroxisome proliferator-activated receptor-gamma contributes to the inhibitory effects of Embelin on colon carcinogenesis. Cancer Res 2009; 69: 4776-4783.

  • 10.

    Takano S, Kubota T, Nishibori H, Hasegawa H, Ishii Y, Nitori N, et al. Pioglitazone, a ligand for peroxisome proliferator-activated receptor-gamma acts as an inhibitor of colon cancer liver metastasis. Anticancer Res 2008; 28: 3593-3599.

  • 11.

    Ogino S, Shima K, Baba Y, Nosho K, Irahara N, Kure S, et al. Colorectal cancer expression of peroxisome proliferator-activated receptor gamma (PPARG, PPARgamma) is associated with good prognosis. Gastroenterology 2009; 136: 1242-1250.

  • 12.

    Pancione M, Forte N, Sabatino L, Tomaselli E, Parente D, Febbraro A, Colantuoni V. Reduced beta-catenin and peroxisome proliferatoractivated receptor-gamma expression levels are associated with colorectal cancer metastatic progression: correlation with tumor-associated macrophages, cyclooxygenase 2, and patient outcome. Hum Pathol 2009; 40: 714-725.

  • 13.

    Onsory KH, Mousavi M, Haji Mehdi Nouri Z, Vahabi Barzi N. Association between estrogen and progesterone receptors gene polymorphisms with prostate cancer. Koomesh 2016; 17: 455-463.

  • 14.

    Fujisawa T, Sugiyama M, Tomimoto A, Wada K, Endo H, Takahashi H, et al. Inhibition of peroxisome proliferator-activated receptor gamma promotes tumorigenesis through activation of the beta-catenin/T cell factor (TCF) pathway in the mouse intestine. J Pharmacol Sci 2008; 108: 535-544.

  • 15.

    Calder PC. Dietary fatty acids and the immune system. Nutr Rev 1998; 56: S70-83.

  • 16.

    Calder PC. Polyunsaturated fatty acids, inflammatory processes and inflammatory bowel diseases. Mol Nutr Food Res 2008; 52: 885-897.

  • 17.

    Tontonoz P, Nagy L, Alvarez JG, Thomazy VA, Evans RM. PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL. Cell 1998; 93: 241-252.

  • 18.

    Thompson EA. PPARgamma physiology and pathology in gastrointestinal epithelial cells. Mol Cells 2007; 24: 167-176.

  • 19.

    Clark RB, Bishop-Bailey D, Estrada-Hernandez T, Hla T, Puddington L, Padula SJ. The nuclear receptor PPAR gamma and immunoregulation: PPAR gamma mediates inhibition of helper T cell responses. J Immunol 2000; 164: 1364-1371.

  • 20.

    Hontecillas R, Wannemeulher MJ, Zimmerman DR, Hutto DL, WilsonJH, Ahn DU, Bassaganya-Riera J. Nutritional regulation of porcine bacterial-induced colitis by conjugated linoleic acid. J Nutr 2002; 132: 2019-2027.

  • 21.

    McNeel RL, Smith EO, Mersmann HJ. Isomers of conjugated linoleic acid modulate human preadipocyte differentiation. In Vitro Cell Dev Biol Anim 2003; 39: 375-382.

  • 22.

    Meadus WJ, MacInnis R, Dugan ME. Prolonged dietary treatment with conjugated linoleic acid stimulates porcine muscle peroxisome proliferator activated receptor gamma and glutamine-fructose aminotransferase gene expression in vivo. J Mol Endocrinol 2002; 28: 79-86.

  • 23.

    Kohno H, Suzuki R, Yasui Y, Hosokawa M, Miyashita K, Tanaka T. Pomegranate seed oil rich in conjugated linolenic acid suppresses chemically induced colon carcinogenesis in rats. Cancer Sci 2004; 95: 481-486.

  • 24.

    Bassaganya-Riera J, Reynolds K, Martino-Catt S, Cui Y, Hennighausen L, Gonzalez F, et al. Activation of PPAR gamma and delta by conjugated linoleic acid mediates protection from experimental inflammatory bowel disease. Gastroenterology 2004; 127: 777-791.

  • 25.

    Bassaganya-Riera J, Hontecillas R, Beitz DC. Colonic anti-inflammatory mechanisms of conjugated linoleic acid. Clin Nutr 2002; 21: 451-459.

  • 26.

    Bassaganya-Riera J, Hontecillas R. CLA and n-3 PUFA differentially modulate clinical activity and colonic PPAR-responsive gene expression in a pig model of experimental IBD. Clin Nutr 2006; 25: 454-465.

  • 27.

    Serini S, Piccioni E, Merendino N, Calviello G. Dietary polyunsaturated fatty acids as inducers of apoptosis: implications for cancer. Apoptosis 2009; 14: 135-152.

  • 28.

    OShea M, Bassaganya-Riera J, Mohede IC. Immunomodulatory properties of conjugated linoleic acid. Am J Clin Nutr 2004; 79: S1199-1206.

  • 29.

    Joanna Kocot1 AF, Magorzata Kieczykowska1, CE, Wojciech Dabrowski2 G, et al. Total antioxidant Status value and superoxide dismutase activity in human colorectal cancer tissue depending on the stage of the disease: a pilot study. Adv Clin Exp Med 2013; 22: 431-437.

  • 30.

    Yilmaz N, Aydin O, Yegin A, Tiltak A, Eren E. Increased levels of total oxidant status and decreased activity of arylesterase in migraineurs. Clin Biochem 2011; 44: 832-837.

  • 31.

    Rothem L, Hartman C, Dahan A, Lachter J, Eliakim R, et al. Paraoxonases are associated with intestinal inflammatory diseases and intracellularly localized to the endoplasmic reticulum. Free Radic Biol Med 2007; 43: 730-739.

  • 32.

    Wang H, Wang HS, Zhou BH, Li CL, Zhang F, Wang XF, et al. Epithelial-mesenchymal transition (EMT) induced by TNF- requires AKT/GSK- 3-mediated stabilization of snail in colorectal cancer. PloS One 2013; 8: e56664.

  • 33.

    Park HS, Ryu JH, Ha YL, Park JH. Dietary conjugated linoleic acid (CLA) induces apoptosis of colonic mucosa in 1,2-dimethylhydrazine-treated rats: a possible mechanism of the anticarcinogenic effect by CLA. Br J Nutr 2007; 86: 549-555.

  • 34.

    Sanders S, Teachey M, Ptock A, Kraemer K, Hasselwander O, Henriksen EJ, Baumgard LH. Effects of specific conjugated linoleic acid isomers on growth characteristics in obese Zucker rats. Lipids 2004; 39: 537-543.

  • 35.

    Francesca Maffeia, Cristina Angelonib, Marco Malagutib, Juan Manuel Zolezzi Moragaa, et al. Plasma antioxidant enzymes and clastogenic factors as possible biomarkers of colorectal cancer risk. Mutat Res 2011; 714: 88-92.

  • 36.

    Bulbuller N, Eren E, Ellidag HY, Oner OZ, Sezer C, et al. Diagnostic value of thiols, paraoxonase 1, arylesterase and oxidative balance in colorectal cancer in human. Neoplasma 2013; 60.419-424.

  • 37.

    Malinowska K, Mik M, Dziki , Dziki A, Majsterek I. Evaluation of antioxidant defense in patients with colorectal carcinoma. Pol Przegl Chir 2015; 87: 357-361.

  • 38.

    Skrzydlewska E, Sulkowski S, Koda M, Zalewski B, et al. Lipid peroxidation and antioxidant status in colorectal cancer. World J Gastroenterol 2005; 11: 403-406.

  • 39.

    Kocot J, Kieczykowska M, Dabrowski W, Piat J, Rudzki S, Musik I. Total antioxidant status value and superoxide dismutase activity in human colorectal cancer tissue depending on the stage of the disease: A Pilot Study. Adv Clin Exp Med 2013; 22: 431-437.

  • 40.

    Shiraishi R, Iwakiri R, Fujise T, Kuroki T, Kakimoto T, Takashima T, et al. Conjugated linoleic acid suppresses colon carcinogenesis in azoxymethane-pretreated rats with long-term feeding of diet containing beef tallow. J Gastroenterol 2010; 45: 625-635.

  • 41.

    Larsson SC1, Bergkvist L, Wolk A. High-fat dairy food and conjugated linoleic acid intakes in relation to colorectal cancer incidence in the Swedish Mammography Cohort1. Am J Clin Nutr 2005; 82: 894-900##.